Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 22095569.
- Also identified by DOI 10.1093/cid/cir791 and PMC identifier 3245728.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twelve trachoma-hyperendemic communities were treated with 3 annual mass azithromycin distributions. Children aged 0-9 years were monitored 1 year following the third treatment. An RNA-based test detected ocular chlamydial infection in more children than did a DNA-based test (6.9% vs 4.2%), and in a larger number of communities (8 vs 7).
Medical subject headings
- Anti-Bacterial Agents
- Azithromycin
- Chlamydia trachomatis
- RNA, Bacterial
- RNA, Ribosomal
- Trachoma